Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study

Journal of Affective Disorders

Volumn 183, Issue , 2015, Pages 159-165

  Toffol, Elena ^a   Hätönen, Taina ^b,c   Tanskanen, Antti ^d   Lönnqvist, Jouko ^a,c   Wahlbeck, Kristian ^a,e   Joffe, Grigori ^f   Tiihonen, Jari ^d   Haukka, Jari ^a,c   Partonen, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Finnish Student Health Service   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Psychotherapy Clinic   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Abbreviations BPD bipolar disorder; HDR hospital discharge register; MSM marginal structural model; SGA second generation antipsychotic

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID; LITHIUM DERIVATIVE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; CAUSE OF DEATH; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; AGED; FINLAND; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGISTER; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COHORT STUDIES; FEMALE; FINLAND; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; REGISTRIES; SUICIDE;

EID: 84929615536     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.04.055     Document Type: Article

References (65)

1. M. Abe, E.D. Herzog, and G.D. Block Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons Neuroreport 11 2000 3261 3264
2. E.P. Ahearn, P. Chen, M. Hertzberg, M. Cornette, L. Suvalsky, D. Cooley-Olson, J. Swanlund, J. Eickhoff, T. Becker, and D. Krahn Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics J. Affect. Disord. 145 2013 77 82
3. A.C. Altamura, R. Bassetti, S. Bignotti, R. Pioli, and E. Mundo Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study Schizophr. Res. 60 2003 47 55
4. P.K. Andersen, Ø. Borgan, R.D. Gill, and N. Keiding Statistical models based on counting processes 1993 Springer-Verlag New York
5. R.F. Bachmann, R.J. Schloesser, T.D. Gould, and H.K. Manji Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics Mol. Neurobiol. 32 2005 173 202
6. R.J. Baldessarini, L. Tondo, P. Davis, M. Pompili, F.K. Goodwin, and J. Hennen Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review Bipolar Disord. 8 2006 625 639
7. R.J. Baldessarini, and L. Tondo Lithium and suicidal risk Bipolar Disord. 10 2008 114 115
8. C.E. Bearden, P.M. Thompson, M. Dalwani, K.M. Hayashi, A.D. Lee, M. Nicoletti, M. Trakhtenbroit, D.C. Glahn, P. Brambilla, R.B. Sassi, A.G. Mallinger, E. Frank, D.J. Kupfer, and J.C. Soares Greater cortical gray matter density in lithium-treated patients with bipolar disorder Biol. Psychiatry 62 2007 7 16
9. J.-M. Beaulieu, T.D. Sotnikova, W.-D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, and M.G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Natl. Acad. Sci. USA 101 2004 5099 5104
10. A. Carlborg, L. Ferntoft, M. Thuresson, and J. Bodegard Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study Bipolar Disord. 2014 10.1111/bdi.12234
11. G. Chen, M.I. Masana, and H.K. Manji Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo Bipolar Disord. 2 2000 217 236
12. A. Cipriani, K. Hawton, S. Stockton, and J.R. Geddes Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ 346 2013 f3646
13. J.C. Collins, and B.H. McFarland Divalproex, lithium and suicide among Medicaid patients with bipolar disorder J. Affect. Disord. 107 2008 23 28
14. E. Di Daniel, L. Cheng, P.R. Maycox, and A.W. Mudge The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters Mol. Cell. Neurosci. 32 2006 27 36
15. K.N. Fountoulakis, E. Vieta, C. Bouras, G. Notaridis, P. Giannakopoulos, G. Kaprinis, and H. Akiskal A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int. J. Neuropsychopharmacol. 11 2008 269 287
16. J.R. Geddes, S. Burgess, K. Hawton, K. Jamison, and G.M. Goodwin Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials Am. J. Psychiatry 161 2004 217 222
17. J.R. Geddes, and D.J. Miklowitz Treatment of bipolar disorder Lancet 381 2013 1672 1682
18. S.N. Ghaemi, A.P. Wingo, M.A. Filkowski, and R.J. Baldessarini Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks Acta. Psychiatr. Scand. 118 2008 347 356
19. M. Gitlin, and M.A. Frye Maintenance therapies in bipolar disorders Bipolar Disord. 14 Suppl. 2 2012 51 65
20. F.K. Goodwin, B. Fireman, G.E. Simon, E.M. Hunkeler, J. Lee, and D. Revicki Suicide risk in bipolar disorder during treatment with lithium and divalproex JAMA 290 2003 1467 1473
21. T.D. Gould, J.A. Quiroz, J. Singh, C.A. Zarate Jr., and H.K. Manji Emerging experimental therapeutics for bipolar disorder: insights from molecular and cellular actions of current mood stabilizers Mol. Psychiatry 9 2004 734 755
22. E.C. Harris, and B. Barraclough Suicide as an outcome for mental disorders: a meta-analysis Br. J. Psychiatry 170 1997 205 228
23. M.A. Hernán, B. Brumback, and J.M. Robins Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men Epidemiology 11 2000 561 570
24. J.P. Houston, J. Ahl, A.L. Meyers, C.J. Kaiser, M. Tohen, and R.J. Baldessarini Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex J. Clin. Psychiatry 67 2006 1246 1252
25. C. Iitaka, K. Miyazaki, T. Akaike, and N. Ishida A role for glycogen synthase kinase-3β in the mammalian circadian clock J. Biol. Chem. 280 2005 29397 29402
26. E. Isometsä, R. Sund, and S. Pirkola Post-discharge suicides of inpatients with bipolar disorder in Finland Bipolar Disord. 16 2014 867 874
27. S.A. Kaladchibachi, B. Doble, N. Anthopoulos, J.R. Woodgett, and A.S. Manoukian Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium J. Circadian. Rhythm. 5 2007 3
28. L.V. Kessing, L. Søndergård, K. Kvist, and P.K. Andersen Suicide risk in patients treated with lithium Arch. Gen. Psychiatry 62 2005 860 866
29. R.J. Koek, B.I. Yerevanian, and J. Mintz Subtypes of antipsychotics and suicidal behavior in bipolar disorder J. Affect. Disord. 143 2012 27 33
30. T.M. Laursen, T. Munk-Olsen, M. Nordentoft, and P.B. Mortensen Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia J. Clin. Psychiatry 68 2007 899 907
31. T.M. Laursen, K. Wahlbeck, J. Hällgren, J. Westman, U. Ösby, H. Alinaghizadeh, M. Gissler, and M. Nordentoft Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries PLoS ONE 8 2013 e67133
32. Y. Leng, M.-H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.-M. Chuang Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition J. Neurosci. 28 2008 2576 2588
33. A.C. Leon, J.G. Fiedorowicz, D.A. Solomon, C. Li, W.H. Coryell, J. Endicott, J. Fawcett, and M.B. Keller Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders J. Clin. Psychiatry 75 2014 720 727
34. G.S. Malhi, M. Tanious, P. Das, C.M. Coulston, and M. Berk Potential mechanisms of action of lithium in bipolar disorder. Current understanding CNS Drugs. 27 2013 135 153
35. H.K. Manji, and R.H. Lenox Signaling: cellular insights into pathophysiology of bipolar disorder Biol. Psychiatry 48 2000 518 530
36. H.K. Manji, G.J. Moore, and G. Chen Clinical and preclinical evidence for the neutrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness Biol. Psychiatry 48 2000 740 754
37. H.Y. Meltzer, L. Alphs, A.I. Green, A.C. Altamura, R. Anand, A. Bertoldi, M. Bourgeois, G. Chouinard, M.Z. Islam, J. Kane, R. Krishnan, J.P. Lindenmayer, S. Potkin, and International Suicide Prevention Trial Study Group Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT) Arch. Gen. Psychiatry 60 2003 82 91
38. H.Y. Meltzer, and G. Okayli Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment Am. J. Psychiatry 152 1995 183 190
39. K.R. Merikangas, H.S. Akiskal, J. Angst, P.E. Greenberg, R.M. Hirschfeld, M. Petukhova, and R.C. Kessler Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication Arch. Gen. Psychiatry 64 2007 543 552
40. G.J. Moore, J.M. Bebchuk, I.B. Wilds, G. Chen, and H.K. Manji Lithium-induced increase in human brain grey matter Lancet 356 2000 1241 1242
41. National Institute for Health and Clinical Excellence. Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. . September 2014 (accessed 02.12.14.).
42. S.R. Offerman, J.A. Alsop, J. Lee, and J.F. Holmes Hospitalized lithium overdose cases reported to the California Poison Control System Clin. Toxicol. 48 2010 443 448
43. M.A. Oquendo, H.C. Galfalvy, D. Currier, M.F. Grunebaum, L. Sher, G.M. Sullivan, A.K. Burke, J. Harkavy-Friedman, M.E. Sublette, R.V. Parsey, and J.J. Mann Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior Am. J. Psychiatry 168 2011 1050 1056
44. J. Perälä, J. Suvisaari, S.I. Saarni, K. Kuoppasalmi, E. Isometsä, S. Pirkola, T. Partonen, A. Tuulio-Henriksson, J. Hintikka, T. Kieseppä, T. Härkänen, S. Koskinen, and J. Lönnqvist Lifetime prevalence of psychotic and bipolar I disorders in a general population Arch. Gen. Psychiatry 64 2007 19 28
45. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: 2011.
46. M.H. Rapaport, and H.K. Manji The effects of lithium on ex vivo cytokine production Biol. Psychiatry 50 2001 217 224
47. J.K. Rybakowski Factors associated with lithium efficacy in bipolar disorder Harv. Rev. Psychiatry 22 2014 353 357
48. E. Severus, M.J. Taylor, C. Sauer, A. Pfennig, P. Ritter, M. Bauer, and J.R. Geddes Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis Int. J. Bipolar. Disord. 2 2014 15
49. K. Soares-Weiser, Y. Bravo Vergel, S. Beynon, G. Dunn, M. Barbieri, S. Duffy, J. Geddes, S. Gilbody, S. Palmer, and N. Woolacott A systemic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder Health. Technol. Assess. 11, III-IV, IX-206 2007
50. R. Sund Quality of the Finnish Hospital Discharge Register: a systematic review Scand. J. Public Health 40 2012 505 515
51. L. Søndergård, A.G. Lopez, P.K. Andersen, and L.V. Kessing Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide Bipolar Disord. 10 2008 87 94
52. M. Tohen, K.N.R. Chengappa, T. Suppes, C.A. Zarate Jr., J.R. Calabrese, C.L. Bowden, G.S. Sachs, D.J. Kupfer, R.W. Baker, R.C. Risser, E.L. Keeter, P.D. Feldman, G.D. Tollefson, and A. Breier Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy Arch. Gen. Psychiatry 59 2002 62 69
53. L. Tondo, G. Isacsson, and R.J. Baldessarini Suicide in bipolar disorder: risk and prevention CNS Drugs 17 2003 491 511
54. H. Valtonen, K. Suominen, O. Mantere, S. Leppämäki, P. Arvilommi, and E.T. Isometsä Suicidal ideation and attempts in bipolar I and II disorders J. Clin. Psychiatry 66 2005 1456 1462
55. L.N. Yatham, S.H. Kennedy, S.V. Parikh, A. Schaffer, S. Beaulieu, M. Alda, C. O'Donovan, G. Macqueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, R. Milev, D.J. Bond, B.N. Frey, B.I. Goldstein, B. Lafer, B. Birmaher, K. Ha, W.A. Nolen, and M. Berk Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar Disord. 15 2013 1 44
56. B.I. Yerevanian, R.J. Koek, and J. Mintz Bipolar pharmacotherapy and suicidal behavior. Part 1: lithium, divalproex and carbamazepine J. Affect. Disord. 103 2007 5 11
57. B.I. Yerevanian, R.J. Koek, and J. Mintz Bipolar pharmacotherapy and suicidal behavior. Part 3: impact of antipsychotics J. Affect. Disord. 103 2007 23 28
58. B.I. Yerevanian, R.J. Koek, J. Mintz, and H.S. Akiskal Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants J. Affect. Disord. 103 2007 13 21
59. A. Yildiz, S. Guleryuz, D.P. Ankerst, D. Öngür, and P.F. Renshaw Protein kinase C inhibition in the treatment of mania Arch. Gen. Psychiatry 65 2008 255 263
60. L. Yin, J. Wang, P.S. Klein, and M.A. Lazar Nuclear receptor rev-erbα is a critical lithium-sensitive component of the circadian clock Science 311 2006 1002 1005
61. R.S.B. Williams, L. Cheng, A.W. Mudge, and A.J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292 295
62. G.E. Wood, L.T. Young, L.P. Reagan, B. Chen, and B.S. McEwen Stress-induced structural remodelling in hippocampus: prevention by lithium treatment Proc. Natl. Acad. Sci. USA 101 2004 3973 3978
63. World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2008. . (accessed 13.08.08.).
64. Y. Zhang, H. Yang, S. Yang, W. Liang, P. Dai, C. Wang, and Y. Zhang Antidepressants for bipolar disorder: a meta-analysis of randomized, double-blind, controlled trials Neural. Regen. Res. 8 2013 2962 2974
65. U. Ösby, L. Brandt, N. Correia, A. Ekholm, and P. Sparén Excess mortality in bipolar and unipolar disorder in Sweden Arch. Gen. Psychiatry 58 2001 844 850